Literature DB >> 3602123

Open field activity and passive avoidance responses in rats after lesion of the central amygdaloid nucleus by electrocoagulation and ibotenic acid.

A S Riolobos, A I Martín García.   

Abstract

The effect of two types of bilateral lesion of the central amygdaloid nucleus on open field activity and on the acquisition of a passive avoidance conditioning in a run way was studied in male Wistar rats. The animals were divided into three groups: sham-operated, a group with lesions caused by electrocoagulation, and a third group lesioned by local application of ibotenic acid. Ibotenic acid is a neurotoxin which damages the neurons but spares the passing fibres. The results indicate that lesion by electrocoagulation leads to a significant increase in the number of rearing responses in the open field. Moreover, lesion by electrocoagulation, but not by ibotenic acid, leads to a deficit in the acquisition of passive avoidance conditioning. This latter result suggests that the deficit is caused by lesion of the fibres crossing the central amygdaloid nucleus and not by the intrinsic elements of the nucleus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3602123     DOI: 10.1016/0031-9384(87)90255-1

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  3 in total

1.  Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference.

Authors:  E E Brown; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Influence of quinolinic acid, an endogenous neurotoxin, on a passive avoidance conditioned reflex in rats.

Authors:  V L Kozlovskii; O G Kenunen; I V Prakh'e
Journal:  Neurosci Behav Physiol       Date:  1991 Jan-Feb

3.  Cortical abnormalities and non-spatial learning deficits in a mouse model of CranioFrontoNasal syndrome.

Authors:  Dina N Arvanitis; Annie Behar; Anne Drougard; Pascal Roullet; Alice Davy
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.